USD 318.04
(1.6%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.76 Billion USD | 8.49% |
2022 | 2.54 Billion USD | 12.61% |
2021 | 2.26 Billion USD | 41.34% |
2020 | 1.59 Billion USD | 15.45% |
2019 | 1.38 Billion USD | -3.28% |
2018 | 1.43 Billion USD | -17.27% |
2017 | 1.73 Billion USD | 12.99% |
2016 | 1.53 Billion USD | 22.46% |
2015 | 1.25 Billion USD | 45.87% |
2014 | 857.61 Million USD | 16.09% |
2013 | 738.73 Million USD | 23.88% |
2012 | 596.33 Million USD | -4.01% |
2011 | 621.21 Million USD | 16.88% |
2010 | 531.47 Million USD | 21.55% |
2009 | 437.25 Million USD | 15.54% |
2008 | 378.44 Million USD | 20.51% |
2007 | 314.04 Million USD | 25.35% |
2006 | 250.53 Million USD | 39.65% |
2005 | 179.4 Million USD | 74.15% |
2004 | 103.01 Million USD | 51.78% |
2003 | 67.87 Million USD | 112.71% |
2002 | -534.13 Million USD | -1280.95% |
2001 | 45.22 Million USD | -85.18% |
2000 | 305.19 Million USD | 81.37% |
1999 | 168.27 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.09 Billion USD | 50.28% |
2024 Q2 | 1.07 Billion USD | -1.19% |
2024 Q3 | 722 Million USD | -33.02% |
2023 Q3 | 8.18 Billion USD | 1109.6% |
2023 Q4 | 726 Million USD | -91.13% |
2023 Q1 | 651 Million USD | -5.79% |
2023 Q2 | 677 Million USD | 3.99% |
2023 FY | 2.76 Billion USD | 8.49% |
2022 Q1 | 627 Million USD | -2.79% |
2022 Q3 | 621 Million USD | 2.48% |
2022 Q4 | 691 Million USD | 11.27% |
2022 FY | 2.54 Billion USD | 12.61% |
2022 Q2 | 606 Million USD | -3.35% |
2021 Q4 | 645 Million USD | 13.96% |
2021 Q1 | 526 Million USD | 6.05% |
2021 FY | 2.26 Billion USD | 41.34% |
2021 Q2 | 523 Million USD | -0.57% |
2021 Q3 | 566 Million USD | 8.22% |
2020 Q2 | 368 Million USD | 7.92% |
2020 FY | 1.59 Billion USD | 15.45% |
2020 Q1 | 341 Million USD | -6.32% |
2020 Q4 | 496 Million USD | 25.89% |
2020 Q3 | 394 Million USD | 7.07% |
2019 FY | 1.38 Billion USD | -3.28% |
2019 Q1 | 327 Million USD | -8.66% |
2019 Q2 | 350 Million USD | 7.03% |
2019 Q4 | 364 Million USD | 5.81% |
2019 Q3 | 344 Million USD | -1.71% |
2018 FY | 1.43 Billion USD | -17.27% |
2018 Q4 | 358 Million USD | 6.55% |
2018 Q2 | 360 Million USD | -4.76% |
2018 Q1 | 378 Million USD | -4.3% |
2018 Q3 | 336 Million USD | -6.67% |
2017 Q2 | 442 Million USD | -7.53% |
2017 Q1 | 478 Million USD | 20.71% |
2017 FY | 1.73 Billion USD | 12.99% |
2017 Q3 | 416 Million USD | -5.88% |
2017 Q4 | 395 Million USD | -5.05% |
2016 Q1 | 372 Million USD | 7.83% |
2016 Q3 | 379 Million USD | -1.56% |
2016 Q4 | 396 Million USD | 4.49% |
2016 Q2 | 385 Million USD | 3.49% |
2016 FY | 1.53 Billion USD | 22.46% |
2015 Q2 | 311.64 Million USD | 10.87% |
2015 Q4 | 345 Million USD | 10.04% |
2015 Q3 | 313.53 Million USD | 0.61% |
2015 Q1 | 281.08 Million USD | 22.44% |
2015 FY | 1.25 Billion USD | 45.87% |
2014 FY | 857.61 Million USD | 16.09% |
2014 Q4 | 229.57 Million USD | 13.02% |
2014 Q3 | 203.12 Million USD | -6.02% |
2014 Q2 | 216.14 Million USD | 3.53% |
2014 Q1 | 208.77 Million USD | 0.71% |
2013 Q4 | 207.3 Million USD | 6.25% |
2013 Q2 | 178.49 Million USD | 12.99% |
2013 Q3 | 195.1 Million USD | 9.31% |
2013 Q1 | 157.97 Million USD | -6.9% |
2013 FY | 738.73 Million USD | 23.88% |
2012 Q3 | 181.42 Million USD | -3.24% |
2012 Q4 | 169.67 Million USD | -6.48% |
2012 Q2 | 187.5 Million USD | 4.94% |
2012 Q1 | 178.67 Million USD | -1.3% |
2012 FY | 596.33 Million USD | -4.01% |
2011 Q2 | 147.12 Million USD | 2.41% |
2011 FY | 621.21 Million USD | 16.88% |
2011 Q4 | 181.02 Million USD | 21.16% |
2011 Q3 | 149.41 Million USD | 1.56% |
2011 Q1 | 143.65 Million USD | -2.96% |
2010 FY | 531.47 Million USD | 21.55% |
2010 Q2 | 124.29 Million USD | 0.65% |
2010 Q1 | 123.48 Million USD | -1.66% |
2010 Q3 | 135.65 Million USD | 9.14% |
2010 Q4 | 148.04 Million USD | 9.13% |
2009 FY | 437.25 Million USD | 15.54% |
2009 Q1 | 100.56 Million USD | 0.3% |
2009 Q2 | 103.65 Million USD | 3.08% |
2009 Q3 | 107.46 Million USD | 3.68% |
2009 Q4 | 125.57 Million USD | 16.85% |
2008 Q2 | 95.4 Million USD | 10.62% |
2008 Q1 | 86.24 Million USD | -3.03% |
2008 FY | 378.44 Million USD | 20.51% |
2008 Q4 | 100.25 Million USD | 3.84% |
2008 Q3 | 96.54 Million USD | 1.2% |
2007 FY | 314.04 Million USD | 25.35% |
2007 Q3 | 81.31 Million USD | 118.36% |
2007 Q2 | -442.9 Million USD | -734.26% |
2007 Q1 | 69.83 Million USD | 3.85% |
2007 Q4 | 88.93 Million USD | 9.37% |
2006 Q1 | 55.97 Million USD | 9.91% |
2006 Q3 | 66.13 Million USD | 8.11% |
2006 Q4 | 67.24 Million USD | 1.67% |
2006 FY | 250.53 Million USD | 39.65% |
2006 Q2 | 61.17 Million USD | 9.3% |
2005 FY | 179.4 Million USD | 74.15% |
2005 Q2 | 40.61 Million USD | 10.54% |
2005 Q1 | 36.74 Million USD | 7.48% |
2005 Q4 | 50.92 Million USD | -0.38% |
2005 Q3 | 51.11 Million USD | 25.85% |
2004 Q3 | 29.2 Million USD | 41.91% |
2004 Q4 | 34.18 Million USD | 17.08% |
2004 FY | 103.01 Million USD | 51.78% |
2004 Q2 | 20.57 Million USD | 7.97% |
2004 Q1 | 19.05 Million USD | 13.05% |
2003 Q1 | -164.04 Million USD | 0.0% |
2003 FY | 67.87 Million USD | 112.71% |
2003 Q4 | 16.85 Million USD | -7.36% |
2003 Q3 | 18.19 Million USD | 8.34% |
2003 Q2 | 16.79 Million USD | 110.24% |
2002 FY | -534.13 Million USD | -1280.95% |
2001 FY | 45.22 Million USD | -85.18% |
2000 FY | 305.19 Million USD | 81.37% |
1999 FY | 168.27 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Cigna Corporation | 186.65 Billion USD | 98.521% |
Centene Corporation | 28.61 Billion USD | 90.35% |
CVS Health Corporation | 40.68 Billion USD | 93.214% |
Elevance Health Inc. | 36.23 Billion USD | 92.381% |
Humana Inc. | 102.36 Billion USD | 97.303% |
Oscar Health, Inc. | 6.09 Billion USD | 54.726% |
UnitedHealth Group Incorporated | 339.26 Billion USD | 99.186% |